Hydroxychloroquine-induced Acute Generalized Exanthematous Pustulosis (AGEP) Treated with Secukinumab.
Yawen Wang,Yanting Liu,Cheng Feng,Mei Wang,Qiong Wang,Songmei Geng
DOI: https://doi.org/10.1111/jdv.19875
2024-01-01
Abstract:Journal of the European Academy of Dermatology and VenereologyEarly View LETTER TO THE EDITOR Hydroxychloroquine-induced acute generalized exanthematous pustulosis (AGEP) treated with secukinumab Yawen Wang, Yawen Wang orcid.org/0009-0002-2733-7917 Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorYanting Liu, Yanting Liu orcid.org/0009-0006-3236-0360 Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorCheng Feng, Cheng Feng Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorMei Wang, Mei Wang Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorQiong Wang, Qiong Wang Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorSongmei Geng, Corresponding Author Songmei Geng [email protected] orcid.org/0000-0001-8731-6267 Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, China Correspondence Songmei Geng, Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, No. 157 Xi Wu Road, Xi'an, Shaanxi Province 710004, China. Email: [email protected]Search for more papers by this author Yawen Wang, Yawen Wang orcid.org/0009-0002-2733-7917 Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorYanting Liu, Yanting Liu orcid.org/0009-0006-3236-0360 Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorCheng Feng, Cheng Feng Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorMei Wang, Mei Wang Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorQiong Wang, Qiong Wang Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, ChinaSearch for more papers by this authorSongmei Geng, Corresponding Author Songmei Geng [email protected] orcid.org/0000-0001-8731-6267 Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, Xi'an, China Correspondence Songmei Geng, Department of Dermatology, Northwest Hospital, Xi'an Jiaotong University, No. 157 Xi Wu Road, Xi'an, Shaanxi Province 710004, China. Email: [email protected]Search for more papers by this author First published: 24 February 2024 https://doi.org/10.1111/jdv.19875 Yawen Wang and Yanting Liu contributed equally to this article. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Open Research DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request. REFERENCES 1Lee EY, Koh MJA. Acute generalized exanthematous pustulosis in children and adolescents in Singapore: a ten-year retrospective review. Pediatr Dermatol. 2021; 38(2): 424–430. 10.1111/pde.14482 PubMedWeb of Science®Google Scholar 2Chaabouni R, Bahloul E, Ennouri M, Atheymen R, Sellami K, Marrakchi S, et al. Hydroxychloroquine-induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature. Int J Dermatol. 2021; 60(6): 742–748. 10.1111/ijd.15419 CASPubMedWeb of Science®Google Scholar 3Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012; 42(2): 145–153. 10.1007/s12016-010-8243-x CASPubMedWeb of Science®Google Scholar 4Sharma AN, Mesinkovska NA, Paravar T. Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review. J Am Acad Dermatol. 2020; 83(2): 563–578. 10.1016/j.jaad.2020.04.024 CASPubMedWeb of Science®Google Scholar 5Matsuda-Hirose H, Sho Y, Yamate T, Nakamura Y, Saito K, Takeo N, et al. Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate. J Dermatol. 2020; 47(2): e53–e54. 10.1111/1346-8138.15185 PubMedWeb of Science®Google Scholar 6Zhang L, Xu Q, Lin T, Ruan S, Lin M, Bao C, et al. Case report: successful treatment of acute generalized Exanthematous pustulosis with Secukinumab. Front Med. 2021; 8:758354. 10.3389/fmed.2021.758354 Google Scholar 7Gualtieri B, Solimani F, Hertl M, Buhl T, Möbs C, Pfützner W. Interleukin 17 as a therapeutic target of acute generalized exanthematous pustulosis (AGEP). J Allergy Clin Immunol Pract. 2020; 8(6): 2081–2084. 10.1016/j.jaip.2020.01.045 PubMedGoogle Scholar 8Munshi M, Junge A, Gadaldi K, Yawalkar N, Heidemeyer K. Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine. JAAD Case Rep. 2020; 6(7): 634–636. 10.1016/j.jdcr.2020.05.014 PubMedGoogle Scholar 9Meiss F, Helmbold P, Meykadeh N, Gaber G, Marsch W, Fischer M. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases. J Eur Acad Dermatol Venereol. 2007; 21(5): 717–719. 10.1111/j.1468-3083.2006.02026.x CASPubMedWeb of Science®Google Scholar 10Deng L, He B, Ali K, Bu Z. Terbinafine induced acute generalized exanthematous pustulosis treated with adalimumab: recalcitrant to systemic corticosteroid therapy. Clin Cosmet Investig Dermatol. 2023; 16: 9–15. 10.2147/CCID.S391979 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation